{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:32:51Z","timestamp":1791153171822,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.cca.2014.03.029","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T14:10:18Z","timestamp":1396361418000},"page":"290-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["PTH: Potential role in management of heart failure"],"prefix":"10.1016","volume":"433","author":[{"given":"D.","family":"Gruson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Buglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"J.C.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2014.03.029_bb0005","doi-asserted-by":"crossref","first-page":"IV14","DOI":"10.1161\/01.CIR.102.suppl_4.IV-14","article-title":"Congestive heart failure: fifty years of progress","volume":"102","author":"Braunwald","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2014.03.029_bb0010","first-page":"10","article-title":"ACCF\/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"2013","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2014.03.029_bb0015","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.101.5.558","article-title":"Beta-adrenergic receptor blockade in chronic heart failure","volume":"101","author":"Bristow","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2014.03.029_bb0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1373\/clinchem.2011.165720","article-title":"Emerging biomarkers in heart failure","volume":"58","author":"van Kimmenade","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2014.03.029_bb0025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/eurjhf\/hfp035","article-title":"Old and new biomarkers of heart failure","volume":"11","author":"Emdin","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cca.2014.03.029_bb0030","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nm.3196","article-title":"A gut-heart connection in cardiometabolic regulation","volume":"19","author":"Buglioni","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.cca.2014.03.029_bb0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/eurheartj\/eht466","article-title":"Natriuretic peptides in cardiovascular diseases: current use and perspectives","volume":"35","author":"Volpe","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cca.2014.03.029_bb0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/HYPERTENSIONAHA.106.069153","article-title":"Natriuretic peptides: update on peptide release, bioactivity, and clinical use","volume":"50","author":"Richards","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2014.03.029_bb0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0735-1097(92)90167-L","article-title":"The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure","volume":"20","author":"Packer","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2014.03.029_bb0050","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0899-5885(02)00096-5","article-title":"Neurohormone activation","volume":"15","author":"Piano","year":"2003","journal-title":"Crit Care Nurs Clin North Am"},{"key":"10.1016\/j.cca.2014.03.029_bb0055","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling\u2014concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2014.03.029_bb0060","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/eurjhf\/hfp035","article-title":"Old and new biomarkers of heart failure","volume":"11","author":"Emdin","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cca.2014.03.029_bb0065","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1093\/eurheartj\/ehs129","article-title":"Tailored therapy for heart failure: the role of biomarkers","volume":"33","author":"Wollert","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cca.2014.03.029_bb0070","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/j.1523-1755.2004.66013.x","article-title":"Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure","volume":"66","author":"Neves","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2014.03.029_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.hjr.0000114706.27531.01","article-title":"Serum parathyroid hormone levels predict coronary heart disease: the Tromso study","volume":"11","author":"Kamycheva","year":"2004","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.cca.2014.03.029_bb0080","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/1871530311313010012","article-title":"Parathyroid hormone and heart failure: novel biomarker strategy","volume":"13","author":"Altay","year":"2013","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.cca.2014.03.029_bb0085","first-page":"987","article-title":"Increased circulating concentrations of bioactive PTH 1\u201384 in patients with heart failure","volume":"35","author":"Gruson","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.cca.2014.03.029_bb0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2011.05.031","article-title":"Vitamin D metabolism and activity in the parathyroid gland","volume":"347","author":"Bienaime","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cca.2014.03.029_bb0095","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJM200012213432508","article-title":"Hyperparathyroid and hypoparathyroid disorders","volume":"343","author":"Marx","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2014.03.029_bb0100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2009.374","article-title":"Parathyroid hormone measurement in CKD","volume":"77","author":"Souberbielle","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2014.03.029_bb0105","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2265.2006.02663.x","article-title":"Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism","volume":"65","author":"Almqvist","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cca.2014.03.029_bb0110","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2265.2005.02363.x","article-title":"Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism","volume":"63","author":"Ogard","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cca.2014.03.029_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0008-6363(97)00194-6","article-title":"Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide","volume":"37","author":"Schluter","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cca.2014.03.029_bb0120","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.ehj.2003.09.010","article-title":"Parathyroid hormone and left ventricular hypertrophy","volume":"24","author":"Saleh","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cca.2014.03.029_bb0125","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000168620","article-title":"Parathyroid hormone-parathyroid hormone related protein receptor messenger RNA is present in many tissues besides the kidney","volume":"13","author":"Tian","year":"1993","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.cca.2014.03.029_bb0130","first-page":"425","article-title":"Parathyroid hormone-related peptide and cardiovascular system","volume":"17","author":"Halapas","year":"2003","journal-title":"In Vivo"},{"key":"10.1016\/j.cca.2014.03.029_bb0135","doi-asserted-by":"crossref","first-page":"F1215","DOI":"10.1152\/ajprenal.00406.2006","article-title":"Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways","volume":"292","author":"Rashid","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cca.2014.03.029_bb0140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijcard.2008.11.067","article-title":"Parathyroidectomy erase increased myocardial electrical vulnerability in patients with primary hyperparathyroidism","volume":"141","author":"Curione","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cca.2014.03.029_bb0145","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1210\/endo.136.7.7789328","article-title":"The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein","volume":"136","author":"Ogino","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2014.03.029_bb0150","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI110137","article-title":"Effect of parathyroid hormone on rat heart cells","volume":"67","author":"Bogin","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2014.03.029_bb0155","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00005344-200110000-00001","article-title":"Signaling pathway and chronotropic action of parathyroid hormone in isolated perfused rat heart","volume":"38","author":"Shimoyama","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cca.2014.03.029_bb0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.regpep.2011.06.002","article-title":"PTH-receptors regulate norepinephrine release in human heart and kidney","volume":"171","author":"Potthoff","year":"2011","journal-title":"Regul Pept"},{"key":"10.1016\/j.cca.2014.03.029_bb0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s007740050101","article-title":"Calcium paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload","volume":"18","author":"Fujita","year":"2000","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.cca.2014.03.029_bb0170","first-page":"H1998","article-title":"Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes","volume":"264","author":"Smogorzewski","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cca.2014.03.029_bb0175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ki.1989.216","article-title":"Effects of verapamil on the abnormalities in fatty acid oxidation of myocardium","volume":"36","author":"Perna","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2014.03.029_bb0180","first-page":"10","article-title":"Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease","author":"Tomaschitz","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2014.03.029_bb0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cvr\/cvs092","article-title":"Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease","volume":"94","author":"Tomaschitz","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cca.2014.03.029_bb0190","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.CIR.0000155621.10213.06","article-title":"Hyperparathyroidism and the calcium paradox of aldosteronism","volume":"111","author":"Chhokar","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2014.03.029_bb0195","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10557-012-6378-0","article-title":"Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism","volume":"27","author":"Rutledge","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.cca.2014.03.029_bb0200","doi-asserted-by":"crossref","first-page":"H286","DOI":"10.1152\/ajpheart.00535.2005","article-title":"Calcium paradox of aldosteronism and the role of the parathyroid glands","volume":"290","author":"Vidal","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cca.2014.03.029_bb0205","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3858\/emm.2010.42.1.006","article-title":"Parathyroid hormone accelerates decompensation following left ventricular hypertrophy","volume":"42","author":"Cha","year":"2010","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.cca.2014.03.029_bb0210","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/ndt\/gfm849","article-title":"Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study","volume":"23","author":"Melamed","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cca.2014.03.029_bb0215","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jacc.2005.03.055","article-title":"Diuretics and bone loss in rats with aldosteronism","volume":"46","author":"Law","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2014.03.029_bb0220","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/eurheartj\/ehq019","article-title":"Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study","volume":"31","author":"Tomaschitz","year":"2010","journal-title":"Eur Heart J"},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2014.03.029_bb0225","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.33549\/physiolres.932185","article-title":"Parathyroid hormone response to vitamin D insufficiency in elderly males with chronic heart failure","volume":"60","author":"Bozic","year":"2011","journal-title":"Physiol Res"},{"key":"10.1016\/j.cca.2014.03.029_bb0230","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/heartjnl-2012-302779","article-title":"Interrelationship between haemodynamic state and serum intact parathyroid hormone levels in patients with chronic heart failure","volume":"99","author":"Sugimoto","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.cca.2014.03.029_bb0235","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/HYPERTENSIONAHA.113.01910","article-title":"Human interventions to characterize novel relationships between the renin\u2013angiotensin\u2013aldosterone system and parathyroid hormone","volume":"63","author":"Brown","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2014.03.029_bb0240","doi-asserted-by":"crossref","first-page":"776","DOI":"10.7326\/0003-4819-150-11-200906020-00005","article-title":"Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension","volume":"150","author":"Sowers","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cca.2014.03.029_bb0245","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1161\/CIRCULATIONAHA.106.634626","article-title":"High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction","volume":"114","author":"Beygui","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2014.03.029_bb0250","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2014.03.029_bb0255","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrendo.2009.196","article-title":"The FGF23\u2013Klotho axis: endocrine regulation of phosphate homeostasis","volume":"5","author":"Razzaque","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.cca.2014.03.029_bb0260","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2014.03.029_bb0265","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","article-title":"Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population","volume":"207","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2014.03.029_bb0270","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1093\/ndt\/gfq309","article-title":"FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment","volume":"25","author":"Seiler","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cca.2014.03.029_bb0275","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/eurheartj\/ehr215","article-title":"The phosphatonin fibroblast growth factor 23 links calcium\u2013phosphate metabolism with left-ventricular dysfunction and atrial fibrillation","volume":"32","author":"Seiler","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cca.2014.03.029_bb0280","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX","volume":"278","author":"Liu","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2014.03.029_bb0285","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/01.CIR.0000024113.26985.CC","article-title":"Fibroblast growth factor receptor-1 signaling induces osteopontin expression and vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro","volume":"106","author":"Li","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2014.03.029_bb0290","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2014.03.029_bb0295","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.peptides.2012.08.003","article-title":"C-terminal FGF23 is a strong predictor of survival in systolic heart failure","volume":"37","author":"Gruson","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.cca.2014.03.029_bb0300","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/ndt\/gfr208","article-title":"The potential roles of FGF23 and Klotho in the prognosis of renal and cardiovascular diseases","volume":"26","author":"Bernheim","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cca.2014.03.029_bb0305","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study","volume":"152","author":"Parker","year":"2010","journal-title":"Ann Intern Med"},{"issue":"119","key":"10.1016\/j.cca.2014.03.029_bb0310","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"19","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2014.03.029_bb0315","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2014.03.029_bb0320","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1007\/BF03347080","article-title":"Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure","volume":"34","author":"Loncar","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.cca.2014.03.029_bb0325","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jacc.2011.03.069","article-title":"Vitamin D, parathyroid hormone, and cardiovascular events among older adults","volume":"58","author":"Kestenbaum","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2014.03.029_bb0330","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurjhf\/hfq134","article-title":"Plasma parathyroid hormone and risk of congestive heart failure in the community","volume":"12","author":"Hagstrom","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cca.2014.03.029_bb0335","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1530\/EC-12-0033","article-title":"Serum 25-hydroxyvitamin D and parathyroid hormone in relation to plasma B-type natriuretic peptide: the Hoorn Study","volume":"1","author":"van Ballegooijen","year":"2012","journal-title":"Endocr Connect"},{"key":"10.1016\/j.cca.2014.03.029_bb0340","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/eurjhf\/hfs138","article-title":"Dynamics of bone turnover markers in patients with heart failure and following haemodynamic improvement through ventricular assist device implantation","volume":"14","author":"Wu","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cca.2014.03.029_bb0345","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2005.10.006","article-title":"Markers of bone metabolism in congestive heart failure","volume":"366","author":"Zittermann","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2014.03.029_bb0350","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00000441-200601000-00009","article-title":"Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure","volume":"331","author":"Khouzam","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cca.2014.03.029_bb0355","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.clinbiochem.2012.12.002","article-title":"Comparison between intact and bioactive parathyroid hormone assays in patients with severe heart failure","volume":"46","author":"Gruson","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cca.2014.03.029_bb0360","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.amjcard.2011.08.039","article-title":"Relation of serum parathyroid hormone level to severity of heart failure","volume":"109","author":"Altay","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cca.2014.03.029_bb0365","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2014.03.029_bb0370","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/hrt.2008.147652","article-title":"Serum intact parathyroid hormone levels predict hospitalisation for heart failure","volume":"95","author":"Sugimoto","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.cca.2014.03.029_bb0375","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/eurjhf\/hfr016","article-title":"Parathyroid hormone and vitamin D\u2014markers for cardiovascular and all cause mortality in heart failure","volume":"13","author":"Schierbeck","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cca.2014.03.029_bb0380","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/1354750X.2012.685182","article-title":"Usefulness of parathyroid hormone as a predictor of heart failure with preserved ejection fraction","volume":"17","author":"Altay","year":"2012","journal-title":"Biomarkers"},{"key":"10.1016\/j.cca.2014.03.029_bb0385","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1309\/AJCPLGCZR7IPVHA7","article-title":"Performance characteristics of six intact parathyroid hormone assays","volume":"134","author":"La'ulu","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cca.2014.03.029_bb0390","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1373\/clinchem.2006.071589","article-title":"Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions","volume":"52","author":"Cantor","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2014.03.029_bb0395","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1373\/clinchem.2009.137323","article-title":"Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants","volume":"56","author":"Lopez","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2014.03.029_bb0400","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1373\/clinchem.2009.134643","article-title":"Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography\u2013tandem mass spectrometry","volume":"56","author":"Kumar","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2014.03.029_bb0405","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cca.2011.09.034","article-title":"New insights on the stability of the parathyroid hormone as assayed by an automated 3rd generation PTH assay","volume":"413","author":"Cavalier","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2014.03.029_bb0410","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.2215\/CJN.03970609","article-title":"Estimation of the stability of parathyroid hormone when stored at \u221280 degrees C for a long period","volume":"4","author":"Cavalier","year":"2009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114001454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114001454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:42:33Z","timestamp":1648737753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898114001454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":82,"alternative-id":["S0009898114001454"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2014.03.029","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PTH: Potential role in management of heart failure","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2014.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}